Portal de Periódicos da CAPES

INTERCOSTAL MUSCLE BIOPSY STUDIES IN MYASTHENIA GRAVIS: CLINICAL CORRELATIONS AND THE DIRECT EFFECTS OF DRUGS AND MYASTHENIC SERUM *

1981; Wiley; Volume: 377; Issue: 1 Linguagem: Inglês

10.1111/j.1749-6632.1981.tb33758.x

1749-6632

Donald B. Sanders, Yong I. Kim, James F. Howard, T. R. Johns, William H. Muller,

Thyroid and Parathyroid Surgery

Annals of the New York Academy of SciencesVolume 377, Issue 1 p. 544-566 INTERCOSTAL MUSCLE BIOPSY STUDIES IN MYASTHENIA GRAVIS: CLINICAL CORRELATIONS AND THE DIRECT EFFECTS OF DRUGS AND MYASTHENIC SERUM * Donald B. Sanders, Donald B. Sanders Division of Neurology Duke University Medical Center Durham, North Carolina 27710Search for more papers by this authorYong I. Kim, Yong I. Kim Departments of Neurology, Engineering, University of Virginia Medical Center Charlottesville, Virginia 22908 Departments of Biomedical Engineering, University of Virginia Medical Center Charlottesville, Virginia 22908Search for more papers by this authorJames F. Howard Jr., James F. Howard Jr. Department of Neurology University of North Carolina School of Mediciné Chapel Hill, North Carolina 27514Search for more papers by this authorT. R. Johns, T. R. Johns Departments of Neurology, Engineering, University of Virginia Medical Center Charlottesville, Virginia 22908Search for more papers by this authorWilliam H. Muller Jr., William H. Muller Jr. Department of Surgery University of Virginia Medical Center Charlottesville, Virginia 22908Search for more papers by this author Donald B. Sanders, Donald B. Sanders Division of Neurology Duke University Medical Center Durham, North Carolina 27710Search for more papers by this authorYong I. Kim, Yong I. Kim Departments of Neurology, Engineering, University of Virginia Medical Center Charlottesville, Virginia 22908 Departments of Biomedical Engineering, University of Virginia Medical Center Charlottesville, Virginia 22908Search for more papers by this authorJames F. Howard Jr., James F. Howard Jr. Department of Neurology University of North Carolina School of Mediciné Chapel Hill, North Carolina 27514Search for more papers by this authorT. R. Johns, T. R. Johns Departments of Neurology, Engineering, University of Virginia Medical Center Charlottesville, Virginia 22908Search for more papers by this authorWilliam H. Muller Jr., William H. Muller Jr. Department of Surgery University of Virginia Medical Center Charlottesville, Virginia 22908Search for more papers by this author First published: December 1981 https://doi.org/10.1111/j.1749-6632.1981.tb33758.xCitations: 15 * Supported in part by NINCDS Grant NS 12905 and a center grant from the Muscular Dystrophy Association, Inc. AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat References 1 Elmqvist, D., W. W. Hofmann, J. Kugelberg & D. M. J. Quastel. 1964. An electrophysiological investigation of neuromuscular transmission in myasthenia gravis. J. Physiol. (London) 174: 417–434. 2 Elmqvist, D. & E. H. Lambert. 1968. Detailed analysis of neuromuscular transmission in a patient with the myasthenic syndrome sometimes associated with bronchogenic carcinoma. Mayo Clin. Proc. 43: 689–713. 3 Lambert, E. H. & D. Elmqvist. 1971. Quantal components of end-plate potentials in the myasthenic syndrome. Ann. N.Y. Acad. Sci. 183: 183–199. 4 Albuquerque, E. X., J. E. Rash, R. F. Mayer & J. R. Satterfield. 1976. An electrophysiological and morphological study of the neuromuscular junctions in patients with myasthenia gravis. Exp. Neurol. 51: 536–563. 5 Lindstrom, J. M. & E. H. Lambert. 1978. Content of acetylcholine receptor and antibodies bound to receptor in myasthenia gravis, experimental autoimmune myasthenia gravis, and Eaton-Lambert syndrome. Neurology 28: 130–138. 6 Mann, J. D., T. R. Johns & J. F. Campa. 1976. Long-term administration of corticosteroids in myasthenia gravis. Neurology 26: 729–740. 7 Sanders, D. B., J. F. Howard, T. R. Johns & J. F. Campa. 1979. High-dose daily prednisone in the treatment of myasthenia gravis. In Plasmapheresis and the Immunobiology of Myasthenia Gravis. P. Dau, Ed.: 289–306. Houghton Mifflin Publishers, Boston , MA . 8 Sanders, D. B., J. F. Howard & T. R. Johns. 1979. Single fiber electromyography in myasthenia gravis. Neurology 21: 68–76. 9 Stanski, D. R., D. I. Greenblatt & E. Lowenstein. 1978. Kinetics of intravenous and intramuscular morphine. Clin. Pharmacol. Ther. 24: 52–59. 10 Takeuchi, N. 1958. The effect of temperature on the neuromuscular junction of the frog. Jap. J. Physiol. 8: 391–404. 11 Katz, B & S. Thesleff. 1957. On the factors which determine the amplitude of the miniature end plate potential. J. Physiol. 137: 267–278. 12 Cull-Candy, S. B., R. Miledi & A. Trautmann. 1979. End-plate currents and acetylcholine noise at normal and myasthenic end plates. J. Physiol. 287: 247–265. 13 Ito, Y., R. Miledi, A. Vincent & J. Newsom-Davis. 1978. Acetylcholine receptors and end-plate electrophysiology in myasthenia gravis. Brain 101: 345–368. 14 Del Castillo, J. & B. Katz. 1954. Quantal components of the end-plate potentials. J. Physiol. 124: 560–573. 15 McAdams, M. W. & A. D. Roses. 1980. Comparison of antigenic sources for acetylcholine receptor antibody assays in myasthenia gravis. Ann. Neurol. 8: 61–66. 16 Kim, Y. I., J. F. Howard & D. B. Sanders. Depressant effects of morphine and meperidine on neuromuscular transmission in normal and myasthenic rat muscle. (In preparation). 17 Caputy, A. J., Y. I. Kim & D. B. Sanders. 1981. The neuromuscular blocking effects of therapeutic concentrations of various antibiotics on normal rat skeletal muscle: a quantitative comparison. J. Pharm. Exp. Ther. 217: 369–378. 18 Eaton, L. M. & E. H. Lambert. 1957. Electromyography and electric stimulation of nerves in diseases of motor unit: observations in the myasthenic syndrome associated with malignant tumors. J. Am. Med. Assoc. 163: 1117–1124. 19 Wilson, R. W., M. D. Ward & T. R. Johns. 1974. Corticosteroids: a direct effect at the neuromuscular junction. Neurology 24: 1091–1095. 20 Kim, Y. I., M. M. Goldner & D. B. Sanders. 1979. Short-term effects of prednisolone on neuromuscular transmission in normal rats and those with experimental autoimmune myasthenia gravis. J. Neurol. Sci. 41: 223–234. 21 Baker, T., W. F. Riker & E. D. Hall. 1977. Effects of a single methyl- prednisolone dose on a facilitatory response of mammalian motor nerve. Arch. Neurol. (Chi.) 34: 349–355. 22 Hofmann, W. W. 1977. Antimyasthenic action of corticosteroids. Arch. Neurol. (Chi.) 34: 356–360. 23 Kim, Y. I., M. M. Goldner & D. B. Sanders. 1980. Facilitatory effects of 4-aminopyridine on normal neuromuscular transmission. Muscle Nerve 3: 105–111. 24 Kim, Y. I., M. M. Goldner & D. B. Sanders. 1980. Facilitatory effects of 4–aminopyridine on neuromuscular transmission in disease states. Muscle Nerve 3: 112–119. 25 Paton, W. D. M. 1957. The action of morphine and related substances on contraction and on acetylcholine output of coaxially stimulated guinea pig ileum. Brit. J. Pharmacol. 11: 119–127. 26 Schaumann, W. 1957. Inhibition by morphine of the release of acetylcholine from the intestine of the guinea pig. Brit. J. Pharmacol. 12: 115–118. 27 Kosterlitz, H. W. & D. I. Wallis. 1964. The action of morphine-like drugs on impulse transmission in mammalian nerve fibers. Br. J. Pharmacol. 22: 499–510. 28 Frederickson, R. C. A. & C. Pinsky. 1971. Morphine impairs release but facilitates acetylcholine action at a skeletal neuromuscular junction. Nature New Bio. 231: 93–94. 29 Pinsky, C. & R. C. A. Frederickson. 1971. Morphine and nalorphine im- pair neuromuscular transmission. Nature New Biol. 231: 94–96. 30 Soteropoulos, G. C. & F. G. Standaert. 1973. Neuromuscular effects of morphine and naloxone. J. Pharmacol. Exp. Thera. 184: 136–142. 31 Bell, K. M. & J. M. H. Rees. 1974. The depressant action of morphine on transmission at a skeletal neuromuscular junction is nonspecific. J. Pharm. Pharmac. 26: 686–691. 32 Frank, G. B. 1975. Opiate drug receptors on excitable membranes. Arch. Int. Pharmacodyn. Ther. 217: 4–17. 33 Frank, G. B. 1975. Two mechanisms for the meperidine block of action potential production in frog's skeletal muscle; nonspecific and opiate drug receptor mediated blockade. J. Physiol. 252: 585–601. 34 Frank, G. B. & H. S. Butter. 1975. Effects of morphine and meperidine on action potential production in frog's skeletal muscle fibers. Can. J. Physiol. Pharmacol. 11: 92–96. 35 Cox, B. M. & M. Weinstock. 1966. The effect of analgesic drugs on the release of acetylcholine from electrically stimulated guinea pig ileum. Br. J. Pharmacol. Chemother. 27: 81–92. 36 Pittinger, C. & C. Adamson. 1972. Antibiotic blockade of neuromuscular function. Rev. Pharm. 12: 169–184. 37 Argov, Z. & F. L. Mastaglia. 1979. Disorders of neuromuscular transmission caused by drugs. N. Engl. J. Med. 301: 409–413. 38 Pridgen, J. E. 1956. Respiratory arrest thought to be due to intraperitoneal neomycin. Surgery 40: 571–574. 39 Hokkannen, E. 1969. The aggravating effect of some antibiotics on the neuromuscular blockade in myasthenia gravis. Acta. Neurol. Scand. 40: 346–352. 40 Herishanu, Y. 1969. The effect of streptomycin and colistin on myasthenia patients. Confin. Neurol. 31: 370–373. 41 L'Hommedieu, C., R. Stough, L. Brown, R. Kettrick & R. Polin. 1979. Potentiation of neuromuscular weakness in infant botulism by aminoglycosides. J. Pediat. 95: 1065–1070. 42 Corrado, A. P. & A. O. Ramos. 1958. Neomycin: its curariforni and ganglioplegic actions. Rev. Bras. Bio. 18: 81–85. 43 Vital Brazil, O. 1961. Streptomycin effect on the skeletal muscle stimulation produced by acetylcholine. Arch. Int. Pharmacodyn. Ther. 130: 136. 44 Elmqvist, D. & J. O. Josefsson. 1962. The nature of the neuromuscular block produced by neomycin. Acta. Physiol. Scand. 54: 105–110. 45 Vital Brazil, O. & J. Prado-Franceschi. 1969. The nature of neuromuscular block produced by neomycin and gentamicin. Arch. Int. Pharmacodyn. Ther. 179: 78–85. 46 Lindstrom, J. M., M. E. Seybold, V. A. Lennon, S. Whittingham & D. D. Duane. 1976. Antibody to acetylcholine receptor in myasthenia gravis. Neurology (Minneap.) 26: 1054–1059. 47 Lefvert, A. K., K. Bergstrom, G. Matell, P. O. Osterman and R. Pirskanen. 1978. Determination of acetylcholine receptor antibody in myasthenia gravis: Clinical usefulness and pathogenetic implications. J. Neurol. Neurosurg. Psychiatry 41: 394–403. 48 Albuquerque, E. X., F. J. Lebeda, S. H. Appel, R. Almon, F. C. Kaufman, R. F Mayer, T. Narahashi & J. Z. Yeh. 1976. Effects of normal and myasthenic serum factors on innervated and chronically denervated mammalian muscles. Ann. N.Y. Acad. Sci. 274: 475–492. 49 Howard, J. F. & D. B. Sanders. 1980. Passive transfer of human myasthenia gravis to rats: I. Electrophysiology of the developing neuromuscular block. Neurology (Minneap.) 30: 760–764. 50 Heinmann, S., S. Bevan, R. Kullberg, J. Lindstrom & J. Rice. 1977. Modulation of acetylcholine receptor by antibody against the receptor. Proc. Nat. Acad. Sci. (USA) 74: 3090–3094. 51 Stanley, E. F., & D. B. Drachman. 1978. Effect of myasthenic immuno-globulin on acetylcholine receptors of intact mammalian neuromuscular junctions. Science 200: 1285–1287. 52 Bergstrom, K., C. Franksson, G. Matell, B. Y. Nilsson, A. Persson, G. Von Reis and R. Stensman. Drainage of thoracic duct lymph in twelve patients with myasthenia gravis. Eur. Neurol. 13: 19–30. Citing Literature Volume377, Issue1Myasthenia Gravis: Pathophysiology and ManagementDecember 1981Pages 544-566 ReferencesRelatedInformation